{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:41:54Z","timestamp":1789771314486,"version":"4.0.1"},"reference-count":107,"publisher":"Elsevier BV","issue":"9","content-domain":{"domain":["cell.com","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Endocrinology & Metabolism"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.tem.2013.05.003","type":"journal-article","created":{"date-parts":[[2013,6,21]],"date-time":"2013-06-21T23:46:08Z","timestamp":1371858368000},"page":"421-430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Primary aldosteronism: emerging trends"],"prefix":"10.1016","volume":"24","author":[{"given":"Sandi-Jo","family":"Galati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadeen C.","family":"Cheesman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel A.","family":"Zhuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice C.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2013.05.003_bib0005","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.2010.650","article-title":"US trends in prevalence, awareness, treatment and control of hypertension, 1998\u20132008","volume":"303","author":"Egan","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.tem.2013.05.003_bib0010","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1161\/HYPERTENSIONAHA.111.170308","article-title":"The prevalence of resistant hypertension in the United States, 2003\u20132008","volume":"57","author":"Persell SD","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2013.05.003_bib0015","first-page":"3","article-title":"Presidential address. Part I: Painting background. Part II: Primary aldosteronism, a new clinical syndrome","volume":"45","author":"Conn","year":"1955","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.tem.2013.05.003_bib0020","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0002-9610(64)90252-1","article-title":"Clinical characteristics of primary aldosteronism from analysis of 145 cases","volume":"107","author":"Conn","year":"1964","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.tem.2013.05.003_bib0025","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1001\/jama.1964.03070160046009","article-title":"Plasma renin activity in primary aldosteronism: importance in differential diagnosis and in research of essential hypertension","volume":"190","author":"Conn","year":"1964","journal-title":"JAMA"},{"key":"10.1016\/j.tem.2013.05.003_bib0030","first-page":"1079","article-title":"The evolution of primary aldosteronism, 1954\u20131967","volume":"62","author":"Conn","year":"1966","journal-title":"Harvey Lect."},{"key":"10.1016\/j.tem.2013.05.003_bib0035","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/jama.1968.03140330039007","article-title":"Incidence of primary aldosteronism uncomplicated \u2018essential\u2019 hypertension: a prospective study with elevated aldosterone secretion and suppressed plasma renin activity used as diagnostic criteria","volume":"205","author":"Fishman","year":"1968","journal-title":"JAMA"},{"key":"10.1016\/j.tem.2013.05.003_bib0040","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.7326\/0003-4819-66-6-1079","article-title":"Hypokalemia in the hypertensive patient, with observations on the incidence of primary aldosteronism","volume":"66","author":"Kaplan","year":"1967","journal-title":"Ann. Int. Med."},{"key":"10.1016\/j.tem.2013.05.003_bib0045","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents","volume":"89","author":"Mulatero","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2013.05.003_bib0050","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.tem.2013.05.003_bib0055","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/j.1440-1681.1994.tb02519.x","article-title":"High incidence of primary aldosteronism in 199 patients referred with hypertension","volume":"21","author":"Gordon","year":"1994","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.tem.2013.05.003_bib0060","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1210\/jc.85.8.2854","article-title":"Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore","volume":"85","author":"Loh","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2013.05.003_bib0065","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","article-title":"Hyperaldosteronism among black and white subjects with resistant hypertension","volume":"40","author":"Calhoun","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2013.05.003_bib0070","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0272-6386(01)80117-7","article-title":"Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone\u2013renin ratio","volume":"37","author":"Gallay","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.tem.2013.05.003_bib0075","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/sj.jhh.1001554","article-title":"Prevalence of primary aldosteronism in moderate to severe hypertension in the Central Europe region","volume":"17","author":"Strauch","year":"2003","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.tem.2013.05.003_bib0080","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/1479164109350556","article-title":"Type 2 diabetic patients with resistant hypertension should be screened for primary aldosteronism","volume":"7","author":"Mukherjee","year":"2010","journal-title":"Diab. Vasc. Dis. Res."},{"key":"10.1016\/j.tem.2013.05.003_bib0085","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.2337\/dc07-0031","article-title":"Primary aldosteronism in diabetic subjects with resistant hypertension","volume":"30","author":"Umpierrez","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tem.2013.05.003_bib0090","first-page":"E1","article-title":"Prevalence of primary aldosteronism in hypertensive subjects with hyperglycemia","author":"Li","year":"2012","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.tem.2013.05.003_bib0095","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/1470320310366581","article-title":"Renin\u2013angiotensin\u2013aldosterone system in patients with sleep apnoea: prevalence of primary aldosteronism","volume":"11","author":"Di Murro","year":"2010","journal-title":"J Renin Angiotensin Aldosterone Syst."},{"key":"10.1016\/j.tem.2013.05.003_bib0100","series-title":"Williams Textbook of Endocrinology","first-page":"545","article-title":"Endocrine hypertension","author":"Young","year":"2012"},{"key":"10.1016\/j.tem.2013.05.003_bib0105","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.pcad.2009.12.003","article-title":"Aldosterone and mineralocorticoid receptors in the cardiovascular system","volume":"53","author":"Funder","year":"2010","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.tem.2013.05.003_bib0110","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s11906-012-0297-0","article-title":"The ubiquitous mineralocorticoid receptor: clinical implications","volume":"14","author":"Hawkins","year":"2012","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.tem.2013.05.003_bib0115","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/HYPERTENSIONAHA.110.161653","article-title":"GPR30 expression is required for the mineralocorticoid receptor-independent rapid vascular effects of aldosterone","volume":"57","author":"Gros","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2013.05.003_bib0120","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1097\/HJH.0b013e32833d0177","article-title":"Increased oxidative stress, subclinical inflammation, and myocardial fibrosis markers in primary aldosteronism patients","volume":"28","author":"Stehr","year":"2010","journal-title":"J. Hypertens."},{"key":"10.1016\/j.tem.2013.05.003_bib0125","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1210\/jc.2011-1135","article-title":"Endothelial progenitor cells in primary aldosteronism: a biomarker of severity for aldosterone vasculopathy and prognosis","volume":"96","author":"Wu","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2013.05.003_bib0130","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1210\/jc.2006-0101","article-title":"Changes in extracellular matrix in subcutaneous small resistance arteries of patients with primary aldosteronism","volume":"91","author":"Rizzoni","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2013.05.003_bib0135","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1097\/HJH.0b013e3281268532","article-title":"Increased intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism","volume":"25","author":"Holaj","year":"2007","journal-title":"J. Hypertens."},{"key":"10.1016\/j.tem.2013.05.003_bib0140","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1097\/HJH.0b013e32831286fd","article-title":"Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism","volume":"26","author":"Bernini","year":"2008","journal-title":"J. Hypertens."},{"key":"10.1016\/j.tem.2013.05.003_bib0145","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/01.HYP.27.5.1039","article-title":"Changes in left ventricular anatomy and function in hypertension and primary aldosteronism","volume":"27","author":"Rossi","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2013.05.003_bib0150","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1161\/01.CIR.95.6.1471","article-title":"Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma","volume":"95","author":"Rossi","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.tem.2013.05.003_bib0155","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.amjhyper.2005.05.013","article-title":"Role of aldosterone in left ventricular hypertrophy in hypertension","volume":"19","author":"Matsumura","year":"2006","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.tem.2013.05.003_bib0160","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.tem.2013.05.003_bib0165","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/HYPERTENSIONAHA.108.114140","article-title":"Inappropriate left ventricular mass in patients with primary aldosteronism","volume":"52","author":"Muiesan","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2013.05.003_bib0170","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1097\/HJH.0b013e3283492219","article-title":"Positive relationship of sleep apnea to hyperaldosteronism in an ethnically diverse population","volume":"29","author":"Sim","year":"2011","journal-title":"J. Hypertens."},{"key":"10.1016\/j.tem.2013.05.003_bib0175","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1055\/s-0031-1295412","article-title":"Aldosterone and metabolic syndrome","volume":"44","author":"Fallo","year":"2012","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.tem.2013.05.003_bib0180","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1210\/jc.2008-0251","article-title":"Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients","volume":"93","author":"Rossi","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2013.05.003_bib0185","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1055\/s-0029-1246189","article-title":"Is primary aldosteronism associated with diabetes mellitus? Results of the German Conn's registry","volume":"42","author":"Reincke","year":"2010","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.tem.2013.05.003_bib0190","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.0000230444.01215.6a","article-title":"Renal damage in primary aldosteronism: results of the PAPY study","volume":"48","author":"Rossi","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2013.05.003_bib0195","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/HJH.0b013e328126855b","article-title":"Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment","volume":"25","author":"Novello","year":"2007","journal-title":"J. Hypertens."},{"key":"10.1016\/j.tem.2013.05.003_bib0200","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1210\/jc.2008-1851","article-title":"Participants of German Conn's Registry. Risk factors associated with a low glomerular filtration rate in primary aldosteronism","volume":"94","author":"Reincke","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2013.05.003_bib0205","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1210\/jc.2008-2116","article-title":"Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's registry","volume":"94","author":"Born-Frontsberg","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2013.05.003_bib0210","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1055\/s-0031-1295461","article-title":"Aldosterone and the kidney","volume":"44","author":"Fourkiotis","year":"2012","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.tem.2013.05.003_bib0215","doi-asserted-by":"crossref","DOI":"10.3109\/15622975.2012.665480","article-title":"Gender differences in anxiety and depressive symptoms in patients with primary aldosteronism: a cross-sectional study","author":"Apostolopoulou","year":"2012","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.tem.2013.05.003_bib0220","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1002\/jbmr.1660","article-title":"Bone involvement in aldosteronism","volume":"27","author":"Salcuni","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.tem.2013.05.003_bib0225","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","article-title":"A chimaeric 11 beta-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism in human hypertension","volume":"355","author":"Lifton","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.tem.2013.05.003_bib0230","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/jhh.2010.93","article-title":"Further study of chromosome 7p22 to identify the molecular basis of familial hyperaldosteronism type II","volume":"25","author":"Carss","year":"2011","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.tem.2013.05.003_bib0235","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1210\/jc.2008-0594","article-title":"A novel form of mendelian hypertension featuring non-glucocorticoid remediable aldosteronism","volume":"93","author":"Geller","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2013.05.003_bib0240","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1198785","article-title":"K+ Channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension","volume":"331","author":"Choi","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.tem.2013.05.003_bib0245","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1073\/pnas.1121407109","article-title":"Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5","volume":"109","author":"Scholl","year":"2012","journal-title":"PNAS"},{"key":"10.1016\/j.tem.2013.05.003_bib0250","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/HYPERTENSIONAHA.111.186478","article-title":"Prevalence, clinical and molecular correlates of KCNJ5 mutations in primary aldosteronism","volume":"52","author":"Boulkroun","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2013.05.003_bib0255","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/HYPERTENSIONAHA.111.186239","article-title":"Somatic mutations affecting the selectivity filter of KCNJ5 are frequent in 2 large unselected collections of adrenal aldosteronomas","volume":"59","author":"Azizan","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2013.05.003_bib0260","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1210\/jc.2011-2885","article-title":"Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas","volume":"97","author":"Taguchi","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2013.05.003_bib0265","doi-asserted-by":"crossref","first-page":"E819","DOI":"10.1210\/jc.2011-2965","article-title":"Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculate-like tumors","volume":"97","author":"Azizan","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2013.05.003_bib0270","doi-asserted-by":"crossref","first-page":"E1567","DOI":"10.1210\/jc.2011-3132","article-title":"Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells","volume":"97","author":"Monticone","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2013.05.003_bib0275","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2013.05.003_bib0280","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00004872-200103000-00002","article-title":"Primary aldosteronism: revival of a syndrome","volume":"19","author":"Stowasser","year":"2000","journal-title":"J. Hypertens."},{"key":"10.1016\/j.tem.2013.05.003_bib0285","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00268-001-0033-4","article-title":"Primary aldosteronism: are we diagnosing and operating on too few patients?","volume":"25","author":"Gordon","year":"2001","journal-title":"World J. Surg."},{"key":"10.1016\/j.tem.2013.05.003_bib0290","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1097\/00004872-200311000-00025","article-title":"High rate of detection of primary aldosteronism, including surgically treatable forms, after \u2018non-selective\u2019 screening of hypertensive patients","volume":"21","author":"Stowasser","year":"2003","journal-title":"J. Hypertens."},{"key":"10.1016\/j.tem.2013.05.003_bib0295","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00004872-200402000-00006","article-title":"The challenge of a more robust and reproducible methodology in screening for primary aldosteronism","volume":"22","author":"Gordon","year":"2004","journal-title":"J. Hypertens."},{"key":"10.1016\/j.tem.2013.05.003_bib0300","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1210\/jc.2003-032179","article-title":"Aldosterone to renin ratio in a primary care setting: the Bussalengo study","volume":"89","author":"Olivieri","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.tem.2013.05.003_bib0305","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1055\/s-0031-1295460","article-title":"Factors affecting the aldosterone\/renin ratio","volume":"44","author":"Stowasser","year":"2012","journal-title":"Horm Met Res."},{"key":"10.1016\/j.tem.2013.05.003_bib0310","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/sj.jhh.1002024","article-title":"Optimal use and interpretation of the aldosterone renin ratio to detect aldosterone excess in hypertension","volume":"20","author":"Doi","year":"2006","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.tem.2013.05.003_bib0315","first-page":"597","article-title":"Drug effects on aldosterone\/plasma renin activity ratio in primary aldosteronism","volume":"4","author":"Mulatero","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2013.05.003_bib0320","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3317\/jraas.2001.022","article-title":"Diagnosis and management of primary aldosteronism","volume":"2","author":"Stowasser","year":"2001","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"10.1016\/j.tem.2013.05.003_bib0325","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1365-2265.2002.01613.x","article-title":"Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism","volume":"57","author":"Seifarth","year":"2002","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.tem.2013.05.003_bib0330","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mce.2003.10.006","article-title":"Primary aldosteronism \u2013 careful investigation is essential and rewarding","volume":"217","author":"Stowasser","year":"2004","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.tem.2013.05.003_bib0335","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0889-8529(02)00013-0","article-title":"Use of plasma aldosterone concentration-to-plasma renin activity as a screening test for primary aldosteronism","volume":"31","author":"Montori","year":"2002","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.tem.2013.05.003_bib0340","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1373\/clinchem.2004.041780","article-title":"Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity","volume":"51","author":"Schwartz","year":"2005","journal-title":"Clin. Chem."},{"key":"10.1016\/j.tem.2013.05.003_bib0345","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa033263","article-title":"Serum aldosteronism and the incidence of hypertension in nonhypertensive persons","volume":"351","author":"Vasan","year":"2004","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.tem.2013.05.003_bib0350","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.HYP.0000258554.87444.91","article-title":"Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample","volume":"49","author":"Newton-Cheh","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2013.05.003_bib0355","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1365-2265.2007.02898.x","article-title":"Diagnosis and treatment of low-renin hypertension","volume":"67","author":"Mulatero","year":"2007","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.tem.2013.05.003_bib0360","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ahj.2004.12.005","article-title":"Effects of eplerenone versus losartan in patients with low-renin hypertension","volume":"150","author":"Weinberger","year":"2005","journal-title":"Am. Heart J."},{"key":"10.1016\/j.tem.2013.05.003_bib0365","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/ajh.2009.63","article-title":"Plasma renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized control trial","volume":"22","author":"Egan","year":"2009","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.tem.2013.05.003_bib0370","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1001\/jama.280.13.1168","article-title":"Age-race subgroup compared with renin profile as predictors of blood pressure response to antihypertensive therapy","volume":"280","author":"Preston","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.tem.2013.05.003_bib0375","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ajh.2010.98","article-title":"Plasma renin activity predicts blood pressure responses to \u03b2-blocker and thiazide diuretic monotherapy and add-on therapy for hypertension","volume":"23","author":"Turner","year":"2010","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.tem.2013.05.003_bib0380","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1055\/s-0029-1246186","article-title":"Confirmatory tests in the diagnosis of primary aldosteronism","volume":"42","author":"Mulatero","year":"2010","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.tem.2013.05.003_bib0385","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1210\/jc.2012-1917","article-title":"A clinical prediction score to diagnose unilateral primary aldosteronism","volume":"97","author":"K\u00fcpers","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2013.05.003_bib0390","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/archsurg.141.5.497","article-title":"Primary hyperaldosteronism: effect of adrenal vein sampling on surgical outcome","volume":"141","author":"Nwariaku","year":"2006","journal-title":"Arch. Surg."},{"key":"10.1016\/j.tem.2013.05.003_bib0395","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.surg.2004.06.051","article-title":"Role for adrenal venous sampling in primary aldosteronism","volume":"136","author":"Young","year":"2004","journal-title":"Surgery"},{"key":"10.1016\/j.tem.2013.05.003_bib0400","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.surg.2012.07.007","article-title":"Modification of the protocol for selective adrenal venous sampling results in both a significant increase in the accuracy and necessity of the procedure in the management of patients with primary hyperaldosteronism","volume":"152","author":"Harvey","year":"2012","journal-title":"Surgery"},{"key":"10.1016\/j.tem.2013.05.003_bib0405","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1007\/s00268-012-1695-9","article-title":"Value of adrenal venous sampling for lesion localization in primary aldosteronism","volume":"36","author":"Oh","year":"2012","journal-title":"World J. Surg."},{"key":"10.1016\/j.tem.2013.05.003_bib0410","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1210\/jc.2011-2830","article-title":"The adrenal vein sampling international study (AVIS) for identifying the major subtypes of primary aldosteronism","volume":"97","author":"Rossi","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2013.05.003_bib0415","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1161\/HYPERTENSIONAHA.110.168484","article-title":"Adrenal venous sampling: evaluation of the German Conn's registry","volume":"57","author":"Vonend","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2013.05.003_bib0420","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/HYPERTENSIONAHA.112.197111","article-title":"Observational study mortality in treated primary aldosteronism: the German Conn's registry","volume":"60","author":"Reincke","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2013.05.003_bib0425","doi-asserted-by":"crossref","DOI":"10.1055\/s-0029-1246185","article-title":"Mineralocorticoid antagonists treatment versus surgery in primary aldosteronism","volume":"42","author":"Catena","year":"2010","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.tem.2013.05.003_bib0430","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/ajh.2010.169","article-title":"Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment","volume":"23","author":"Sechi","year":"2010","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.tem.2013.05.003_bib0435","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.107.095448","article-title":"Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism","volume":"50","author":"Catena","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2013.05.003_bib0440","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular outcomes in patients with primary aldosteronism after treatment","volume":"168","author":"Catena","year":"2008","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.tem.2013.05.003_bib0445","first-page":"274","article-title":"Cardiovascular changes in patients with primary aldosteronism after surgical or medical treatment","volume":"35","author":"Bernini","year":"2012","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.tem.2013.05.003_bib0450","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1001\/jama.295.22.2638","article-title":"Long-term renal outcomes in patients with primary aldosteronism","volume":"295","author":"Sechi","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.tem.2013.05.003_bib0455","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1210\/jc.2008-2245","article-title":"Intrarenal hemodynamics in primary aldosteronism before and after treatment","volume":"94","author":"Sechi","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2013.05.003_bib0460","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1530\/EJE-12-0631","article-title":"Effectiveness of eplerenone or spironolactone treatment in preserving renal function in primary aldosteronism","volume":"168","author":"Fourkiotis","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.tem.2013.05.003_bib0465","doi-asserted-by":"crossref","DOI":"10.1097\/HJH.0b013e3280108e6f","article-title":"Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study","volume":"25","author":"Giacchetti","year":"2007","journal-title":"J. Hypertens."},{"key":"10.1016\/j.tem.2013.05.003_bib0470","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1210\/jc.2006-0736","article-title":"Insulin sensitivity in patients with primary aldosteronism: a follow-up study","volume":"91","author":"Catena","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2013.05.003_bib0475","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1210\/jc.2009-1763","article-title":"Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism","volume":"95","author":"Sukor","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2013.05.003_bib0480","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1210\/jc.2011-0138","article-title":"Quality of life in patients with bilateral primary aldosteronism before and during treatment with spironolactone and\/or amiloride, including a comparison with our previously published results in those with unilateral disease treated surgically","volume":"96","author":"Ahmed","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2013.05.003_bib0485","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1046\/j.1365-2125.1999.00070.x","article-title":"Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow-up study","volume":"48","author":"Lim","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.tem.2013.05.003_bib0490","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1677\/ERC-08-0094","article-title":"Medical treatment as an alternative to adrenalectomy in patients with aldosterone-producing adenomas","volume":"15","author":"Karagiannis","year":"2008","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.tem.2013.05.003_bib0495","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0022-3565(25)22580-0","article-title":"Three new epoxy-spirolactone derivatives: characterization in vivo and in vitro","volume":"240","author":"De Gasparo","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tem.2013.05.003_bib0500","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/HJH.0b013e3283455ca5","article-title":"A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism","volume":"29","author":"Parthasarathy","year":"2011","journal-title":"J. Hypertens."},{"key":"10.1016\/j.tem.2013.05.003_bib0505","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00004872-200103000-00001","article-title":"A review of the medical treatment of primary aldosteronism","volume":"19","author":"Lim","year":"2001","journal-title":"J. Hypertens."},{"key":"10.1016\/j.tem.2013.05.003_bib0510","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1097\/HJH.0b013e3283060f0c","article-title":"Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma","volume":"26","author":"Letavernier","year":"2008","journal-title":"J. Hypertens."},{"key":"10.1016\/j.tem.2013.05.003_bib0515","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00268-004-7496-z","article-title":"Long-term follow-up after adrenalectomy for primary aldosteronism","volume":"29","author":"Meyer","year":"2005","journal-title":"World J. Surg."},{"key":"10.1016\/j.tem.2013.05.003_bib0520","doi-asserted-by":"crossref","first-page":"104","DOI":"10.9738\/CC140.1","article-title":"Predictors of successful outcome after adrenalectomy for primary aldosteronism","volume":"97","author":"Wang","year":"2012","journal-title":"Int. Surg."},{"key":"10.1016\/j.tem.2013.05.003_bib0525","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2265.2007.02775.x","article-title":"Primary aldosteronism: renaissance of a syndrome","volume":"66","author":"Young","year":"2007","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.tem.2013.05.003_bib0530","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/0003-4819-131-2-199907200-00005","article-title":"Medical management of aldosterone-producing adenomas","volume":"131","author":"Ghose","year":"1999","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.tem.2013.05.003_bib0535","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1210\/jc.2008-2803","article-title":"Role of unilateral adrenalectomy in bilateral primary aldosteronism: a 22-year single center experience","volume":"94","author":"Sukor","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Trends in Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276013000829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276013000829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T12:25:48Z","timestamp":1746015948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043276013000829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":107,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S1043276013000829"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2013.05.003","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary aldosteronism: emerging trends","name":"articletitle","label":"Article Title"},{"value":"Trends in Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tem.2013.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}